Come see us at The Next Generation DX Summit, Booth 407
Washington, DC, August 20-24, 2018


Dr. Vanessa Tumilasci will host a presentation on August 22, @2:50 pm
''Accelerating Biomarker Validation for Mid and Small size Dx Companies Through a Risk-Benefit Sharing Model''
 

 

Trans-Hit Bio will be attending the Europe Biobank Week

Antwerp - Belgium, September 4-7, 2018
Presenting the abstract ''Can collaborating with Industry make Academic Biobanks sustainable? If so, what do they have to change to work with Industry?''

 

logo logo